Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.2B
Avg Funding
$49.7M
Cities
22

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
South San Francisco, United States
$84.0M
raised

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

Nov 2024
Series B

Founder Contacts

41,000+ verified contacts

Dublin, Ireland
$92.0M
raised

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Monrovia, United States
$120.0M
raised

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$104.5M
raised

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Ecublens, Switzerland
$19.6M
raised

Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Kyoto, Japan
$15.2M
raised

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Pohang, South Korea
$5.0M
raised

Bio Design Lab is a biotechnology company that develops biopharmaceutical products.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$32.5M
raised

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$28.9M
raised

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$175.0M
raised

Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Charlottesville, United States
$12.0M
raised

AgroSpheres develops novel technologies that aim to set a new standard for bio-based delivery of active ingredients.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Ramonville-saint-agne, France
$11.0M
raised

Micropep Technologies is a biotech company that focused on biological alternatives to agrochemicals.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$50.0M
raised

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$6.0M
raised

Amprion is a biotech company that focuses on the diagnosis for brain diseases.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

New York, United States
$45.0M
raised

Helaina is a biotechnology company that focuses on advanced nutrition through the replication of functional proteins.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Milan, Italy
$52.2M
raised

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$100.0M
raised

Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$30.0M
raised

PictorLabs offers virtual staining technology using proprietary models powered by artificial intelligence.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Montréal, Canada
$42.0M
raised

Nomic develops a proteomic technology platform to understand, detect, and treat diseases with DNA nanotechnology.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Watertown, United States
$25.0M
raised

Seismic Therapeutic is a biotechnology company developing machine-learning technology for immunology drug development.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$12.0M
raised

PhoreMost is a new-model drug discovery company based in Cambridge, UK.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Waltham, United States
$50.0M
raised

Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Baar, Switzerland
$48.5M
raised

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$16.3M
raised

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$67.0M
raised

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 176 to 200 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

430 Biotechnology Series B Startups (November 2026) — Page 8 | VCBacked